Close Menu

Cheap and Routine

Jay Flatley, the CEO of Illumina, told the UK's Times that by 2019, the genome sequencing of newborns will be routine and that in three to four years a genome sequence should be available for less than $1,000. "The limitations are sociological; when and where people think it can be applied, the concerns people have about misinformation and the background ethics questions," Flatley says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.